Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream
Background: The study investigated the long-term efficacy of imiquimod 5% cream for LM, with a focus on disease recurrence and the possible prognostic factors of disease-free survival (DFS) in a cohort, with long-term follow-up. Methods: Consecutive patients with histologically confirmed LM were inc...
Main Authors: | S. Morteza Seyed Jafari, Flavia Folini-Huesser, Simone Cazzaniga, Robert E. Hunger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/5/1546 |
Similar Items
-
Topical Imiquimod Treatment of Lentigo Maligna
by: F. Ventura, et al.
Published: (2009-10-01) -
Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment
by: R. Kwak, et al.
Published: (2022-05-01) -
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
by: Silvia Vaienti, et al.
Published: (2023-08-01) -
Challenge in diagnosis and management of lentigo maligna and lentigo maligna melanoma
by: Ika Anggraini, et al.
Published: (2017-08-01) -
Immune thrombocytopenic purpura: A rare side effect in a patient treated with Imiquimod for lentigo maligna
by: E.A. Whatling, et al.
Published: (2017-09-01)